Clinical Trial Update: UTECH: Machine Learning for HIV Prevention Among Substance Using GBMSM [NA]

View source ↗

Summary

The UCLA-led trial evaluating machine learning for HIV prevention among substance-using GBMSM has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Sexually Transmitted Infections

Snippet

Sponsor: University of California, Los Angeles | Conditions: Sexually Transmitted Diseases, HIV Infections | NA | Status: COMPLETED